nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—FKBP1A—Disease—TFDP1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—CDKN1A—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—CDKN1A—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—TP53—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Everolimus—MTOR—RANKL/RANK Signaling Pathway—AKT1—ocular cancer	0.002	0.002	CbGpPWpGaD
Everolimus—MTOR—Cardiac Hypertrophic Response—AKT1—ocular cancer	0.002	0.002	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—HRAS—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Everolimus—MTOR—AMPK Signaling—TP53—ocular cancer	0.00197	0.00197	CbGpPWpGaD
Everolimus—MTOR—mTOR signaling pathway—HRAS—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Everolimus—MTOR—TSH signaling pathway—HRAS—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—E2F1—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—MDM2—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—E2F5—ocular cancer	0.00188	0.00188	CbGpPWpGaD
Everolimus—MTOR—CDC42 signaling events—HRAS—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—MDM2—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—E2F4—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—MDM2—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Everolimus—MTOR—IL4-mediated signaling events—AKT1—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RBL1—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—CDKN1B—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—HRAS—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—AKT1—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—MDM2—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—MDM2—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—MDM2—ocular cancer	0.00173	0.00173	CbGpPWpGaD
Everolimus—MTOR—TSH signaling pathway—AKT1—ocular cancer	0.00173	0.00173	CbGpPWpGaD
Everolimus—MTOR—mTOR signaling pathway—AKT1—ocular cancer	0.00173	0.00173	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—MDM2—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Everolimus—MTOR—Disease—SAG—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—CDKN1B—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—MDM2—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Everolimus—MTOR—Regulation of Telomerase—AKT1—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Everolimus—MTOR—Costimulation by the CD28 family—AKT1—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CDK2—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—CDKN1B—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Everolimus—MTOR—SREBP signalling—AKT1—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Everolimus—MTOR—AMPK Signaling—AKT1—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MAML2—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—CDKN1A—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—MDM2—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MDM2—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—MDM2—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—MDM2—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Everolimus—MTOR—IRS-mediated signalling—HRAS—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—CDKN1B—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—MDM2—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—CDKN1B—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CDK4—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—MDM2—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—CDKN1B—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—CDKN1B—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—E2F3—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—CDKN1A—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—AKT1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Everolimus—MTOR—IRS-related events—HRAS—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—CDKN1A—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—HRAS—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Everolimus—MTOR—Disease—E2F5—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—HRAS—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—HRAS—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—MDM2—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Everolimus—MTOR—Disease—E2F4—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—CDKN1B—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—CDKN1B—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1B—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—CDKN1A—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—CDKN1B—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—CDKN1A—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TFDP1—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—CDKN1A—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Everolimus—MTOR—Disease—RPL39—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Everolimus—MTOR—Disease—RBL1—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—CDKN1A—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—CDKN1B—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—AKT1—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Everolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—RB1—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—CDKN1B—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—CDKN1A—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—CDKN1A—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—HRAS—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—CDKN1A—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—CDKN1A—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Everolimus—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Everolimus—MTOR—PI-3K cascade—AKT1—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—HRAS—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—HRAS—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—AKT1—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—AKT1—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HDAC1—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SAG—ocular cancer	0.0012	0.0012	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—AKT1—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—MDM2—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Everolimus—MTOR—Disease—TFDP1—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MAML2—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—AKT1—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—MDM2—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CDKN2B—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CDKN1B—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—HRAS—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—E2F5—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—HRAS—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—E2F4—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RBL1—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GNA11—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—CDKN1B—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—HRAS—ocular cancer	0.001	0.001	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CDKN1A—ocular cancer	0.00099	0.00099	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—HRAS—ocular cancer	0.000962	0.000962	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—HRAS—ocular cancer	0.000958	0.000958	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—HRAS—ocular cancer	0.000953	0.000953	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000953	0.000953	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—HRAS—ocular cancer	0.000948	0.000948	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—HRAS—ocular cancer	0.000944	0.000944	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—EP300—ocular cancer	0.000942	0.000942	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—AKT1—ocular cancer	0.00094	0.00094	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GNAQ—ocular cancer	0.000939	0.000939	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.00093	0.00093	CbGpPWpGaD
Everolimus—MTOR—Disease—MAML2—ocular cancer	0.00093	0.00093	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—CDKN1A—ocular cancer	0.000929	0.000929	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—AKT1—ocular cancer	0.000925	0.000925	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.0009	0.0009	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00089	0.00089	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000888	0.000888	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—HRAS—ocular cancer	0.000888	0.000888	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—HRAS—ocular cancer	0.000888	0.000888	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—AKT1—ocular cancer	0.000885	0.000885	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—E2F3—ocular cancer	0.000882	0.000882	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—HRAS—ocular cancer	0.00088	0.00088	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000872	0.000872	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—HRAS—ocular cancer	0.000868	0.000868	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—AKT1—ocular cancer	0.00085	0.00085	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HDAC1—ocular cancer	0.000846	0.000846	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—AKT1—ocular cancer	0.000846	0.000846	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—AKT1—ocular cancer	0.000841	0.000841	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000841	0.000841	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—AKT1—ocular cancer	0.000837	0.000837	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—AKT1—ocular cancer	0.000833	0.000833	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—HRAS—ocular cancer	0.000822	0.000822	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000821	0.000821	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TFDP1—ocular cancer	0.00082	0.00082	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000786	0.000786	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—AKT1—ocular cancer	0.000784	0.000784	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000784	0.000784	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—AKT1—ocular cancer	0.000784	0.000784	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—AKT1—ocular cancer	0.000777	0.000777	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.00077	0.00077	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—AKT1—ocular cancer	0.000767	0.000767	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CDKN2B—ocular cancer	0.000759	0.000759	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—AKT1—ocular cancer	0.000725	0.000725	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—E2F1—ocular cancer	0.000696	0.000696	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000694	0.000694	CbGpPWpGaD
Everolimus—MTOR—Disease—HDAC1—ocular cancer	0.00068	0.00068	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—TP53—ocular cancer	0.000674	0.000674	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAML2—ocular cancer	0.000651	0.000651	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—MDM2—ocular cancer	0.000629	0.000629	CbGpPWpGaD
Everolimus—MTOR—Disease—CDKN2B—ocular cancer	0.000609	0.000609	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—HRAS—ocular cancer	0.000605	0.000605	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—MDM2—ocular cancer	0.000604	0.000604	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MDM2—ocular cancer	0.000601	0.000601	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CDKN1B—ocular cancer	0.000574	0.000574	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PSPH—ocular cancer	0.000573	0.000573	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GNA11—ocular cancer	0.000568	0.000568	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CDKN1B—ocular cancer	0.000551	0.000551	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CDKN1B—ocular cancer	0.000549	0.000549	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—AKT1—ocular cancer	0.000534	0.000534	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CDKN1A—ocular cancer	0.00053	0.00053	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GNAQ—ocular cancer	0.000528	0.000528	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CDKN1A—ocular cancer	0.000509	0.000509	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CDKN1A—ocular cancer	0.000506	0.000506	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—EP300—ocular cancer	0.000504	0.000504	CbGpPWpGaD
Everolimus—FKBP1A—Disease—EP300—ocular cancer	0.000482	0.000482	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HDAC1—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CDKN2B—ocular cancer	0.000427	0.000427	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MDM2—ocular cancer	0.000421	0.000421	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MYC—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFB1—ocular cancer	0.000419	0.000419	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—E2F1—ocular cancer	0.000392	0.000392	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CDKN1B—ocular cancer	0.000384	0.000384	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCND1—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Everolimus—MTOR—Immune System—MDM2—ocular cancer	0.000366	0.000366	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CDKN1A—ocular cancer	0.000355	0.000355	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HRAS—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Everolimus—MTOR—Disease—MDM2—ocular cancer	0.000338	0.000338	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EP300—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Everolimus—MTOR—Immune System—CDKN1B—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HRAS—ocular cancer	0.000331	0.000331	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HRAS—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Everolimus—MTOR—Disease—CDKN1B—ocular cancer	0.000309	0.000309	CbGpPWpGaD
Everolimus—MTOR—Immune System—CDKN1A—ocular cancer	0.000309	0.000309	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—AKT1—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MYC—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Everolimus—MTOR—Immune System—EP300—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFB1—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—AKT1—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Everolimus—FKBP1A—Disease—AKT1—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Everolimus—MTOR—Disease—CDKN1A—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Everolimus—MTOR—Disease—EP300—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TP53—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MDM2—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Everolimus—MTOR—Disease—MYC—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFB1—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HRAS—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CDKN1B—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCND1—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AKT1—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Everolimus—MTOR—Immune System—HRAS—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CDKN1A—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EP300—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Everolimus—MTOR—Disease—HRAS—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GNA11—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Everolimus—MTOR—Immune System—AKT1—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MYC—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFB1—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Everolimus—MTOR—Disease—AKT1—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TP53—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HRAS—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AKT1—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EP300—ocular cancer	6.02e-05	6.02e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AKT1—ocular cancer	3.64e-05	3.64e-05	CbGpPWpGaD
